Allergan vet Bob Rhatigan is the new President and Chief Executive Officer (CEO) of Merz North America, and Patrick Urban will serve as Chief Commercial Officer, effective immediately.
In his new role, Mr. Rhatigan will assume responsibility for Merz’s business in North America, leading strategy and operations across the US and Canada. Mr. Rhatigan will join Merz’s global management board and will report directly to Philip Burchard, CEO of Merz Pharma Group.
Prior to joining Merz, Mr. Rhatigan served as Senior Vice President of Allergan’s Facial Aesthetics business, overseeing the US launches and commercial success of their key aesthetic injectable brands. While at Allergan, he also served as Senior Vice President, General Manager and Chief Executive of SkinMedica. Most recently, Bob Rhatigan served as President and Chief Operating Officer at Alphaeon Corporation.
Patrick Urban, who most recently served as interim President and CEO for Merz North America, is the new Chief Commercial Officer, reporting directly to Bob Rhatigan. In this newly-created position, Mr. Urban will play a critical role in driving the commercial success of the Merz Aesthetics portfolio.
Previously, Urban held the role of Vice President, US Aesthetics Sales, where he was responsible for the management of Merz North America’s U.S.-based aesthetics sales force. Prior to joining Merz, Patrick Urban served as Vice President, U.S. Sales for Ulthera, Inc.